Abstract: A defibrillation circuit comprising a gas discharge tube and a light source arranged to pre-energize the gas discharge tube in order to provide predictable breakdown conditions of the gas discharge tube. The gas discharge tube may be used as an overvoltage protection device for the defibrillation circuit or for certain parts of the defibrillation circuit. An overvoltage protection device for medical devices is also described. The overvoltage protection device comprises a gas discharge tube and a light source arranged to pre-energize the gas discharge tube in order to provide predictable breakdown conditions of the gas discharge tube.

Abstract: The present disclosure provides a system and method of determining a risk score for triage. In particular, a system is provided for providing an assessment of risk of a cardiac event for a patient, for example an incoming patient to a hospital emergency department complaining of chest pain. In the disclosure, the system includes an input device for measuring physiological data based vital signs parameter of the patient, a twelve-lead electrocardiogram (ECG) device for establishing an ECG obtained from results of the electrocardiography procedure, and determining an ECG parameter and a heart rate variability (HRV) parameter therefrom. An ensemble-based scoring system is further provided, establishing weighted classifier based on past patient data and where the vital signs parameter, the ECG parameter and the HRV parameter are compared to corresponding weighted classifiers to determine a risk score. A corresponding method to determine a risk score for triage is also provided.

Abstract: Apparatus for driving fluid between first and second anatomical sites of a subject is provided, comprising (1) a first electrode, configured to be coupled to the first anatomical site of the subject; (2) a second electrode, configured to be coupled to the second anatomical site of the subject; and (3) a control unit, configured to (i) detect a pressure difference between the first and second anatomical sites, and (ii) in response to the detected pressure difference, drive fluid between the first and second anatomical sites by applying a treatment voltage between the first and second electrodes. Other embodiments are also described.

Abstract: An apparatus for releasably engaging an implantable medical device during delivery includes an elongate, tubular body having an open distal end a plurality of deflectable jaw members extending distally from the distal end of the body and terminating in distal tip portions, and an actuating member slidably disposed within the body and including a distal end portion operable to prevent inward deflection of the jaw members when positioned proximate the distal tip portions. The jaw members are adapted to releasably engage an engagement feature of the implantable medical device.

Abstract: An implantable device, including a first electrically non-conductive substrate; a plurality of electrically conductive vias through the first electrically non-conductive substrate; a flip-chip multiplexer circuit attached to the electrically non-conductive substrate using conductive bumps and electrically connected to at least a subset of the plurality of electrically conductive vias; a flip-chip driver circuit attached to the flip-chip multiplexer circuit using conductive bumps; a second electrically non-conductive substrate attached to the flip-chip driver circuit using conductive bumps; discrete passives attached to the second electrically non-conductive substrate; and a cover bonded to the first electrically non-conductive substrate, the cover, the first electrically non-conductive substrate and the electrically conductive vias forming a hermetic package.

Abstract: A blood pump system is implantable in a patient for ventricular support. A pumping chamber has an inlet for receiving blood from a ventricle of the patient. An impeller is received in the pumping chamber. A motor is coupled to the impeller for driving rotation of the impeller. A motor controller is provided for tracking systolic and diastolic phases of a cardiac cycle of the patient and supplying a variable voltage signal to the motor in a variable speed mode to produce a variable impeller speed linked to the cardiac cycle. The impeller speed comprises a ramping up to an elevated speed during the diastolic phase in order to reduce a load on the ventricle at the beginning of the systolic phase.

Abstract: A biosignal measuring device has a first information acquisition module, a second information acquisition module, a first calculation module, a second calculation module, a third calculation module, a heartbeat interval estimation module, a determination module, and an output module. The first information acquisition module acquires the pulse wave signal. The second information acquisition module acquires an electrocardiogram signal. The first calculation module calculates a pulse wave velocity based. The second calculation module determines a heartbeat interval. The third calculation module calculates a relationship between pulse wave velocity and the heartbeat interval. The heartbeat interval estimation module estimates an estimated heartbeat interval based on pulse wave velocity and calculated relationship. The determination module determines whether the position of the first and second information acquisition modules has changed based on the heartbeat interval and the estimated heartbeat interval.

Abstract: Techniques, devices, and systems may include screening effective therapies using cortical evoked potentials. In one example, a system may be configured to receive a first sensed cortical evoked potential of a patient that occurred in response to an induced sensation at an anatomical region different from a brain region of the patient and receive a second sensed cortical evoked potential that occurred in response to electrical stimulation delivered to one or more nerves associated with the anatomical region. The electrical stimulation may be at least partially defined by a set of therapy parameter values. The system may also compare a first value of a characteristic of the first sensed cortical evoked potential to a second value of the characteristic of the second sensed cortical evoked potential and determine, based on the comparison, efficacy of a therapy configured to treat a condition associated with the anatomical region.

Abstract: A cardiac assist device is provided that can be deployed in any region of the aorta by minimally invasive techniques by the way of an inventive fastener that affixes the device to the aorta wall at the site of an aortonomy. The devices and methods described herein allow for improved patient outcome.

Abstract: Embodiments of the invention disclose a method and a system for signal analyzing and a processing module of the system. The signal analyzing system includes a plurality of first electrodes, a plurality of second electrodes, and a processing module. The first electrodes transmit a plurality of first input signals. The second electrodes transmit a plurality of second input signals. The processing module generates a body electrical signal according to at least one of the plurality of first input signals and at least one of the plurality of second input signals, generates a first filtered signal corresponding to the plurality of first input signals, generates a second filtered signal corresponding to the plurality of second input signals, and generates a lead signal according to the body electrical signal, the first filtered signal and the second filtered signal.

Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.

Abstract: A cochlear implant system includes: an electrode array implanted within a cochlea; an internal processor in communication with the electrode array; an implanted antenna which is electrically coupled to the internal processor; and a modular external headpiece which is removably positioned over the implanted antenna, the modular external headpiece including a core containing a sound processor for processing sound and providing a corresponding signal to the implanted antenna; and a modular component configured to releasably engage the core and supply electrical power to the core.

Abstract: What is disclosed is a system and method for extracting photoplethysmographic (PPG) signal (i.e., a cardiac signal) on a continuous basis from a time-series signals obtained from video images captured of a subject being monitored for cardiac function in a non-contact remote sensing environment involves the following. First, a time-series signal obtained from video images captured of a region of exposed skin where a photoplethysmographic (PPG) signal of a subject of interest can be registered. A sliding window is then used to define consecutive sequential segments of the time-series signal for processing. Each of the consecutive time-series signal segments is detrended such that low frequency variations and non-stationary components are removed. The detrended signals are processed to obtain, for each segment, a PPG signal. The PPG signal segments are then stitched together using a stitching method, as disclosed herein, to obtain a continuous PPG signal for the subject.

Abstract: An area of a patient can be mapped with a system operable to identify a plurality of locations and save a plurality of locations of a mapping instrument. The mapping instrument can include one or more electrodes that can sense a voltage that can be correlated to a three dimensional location of the electrode at the time of the sensing or measurement. Therefore, a map of an area or volume can be determined based upon the sensing of the plurality of points without the use of an imaging device. An implantable medical device can then be navigated relative to the mapping data.

Abstract: The invention is a method of identifying a preferred location for an electrode array to the neural characteristics of an individual subject. The response to electrical neural stimulation varies from subject to subject and array location to array location. Measure of impedance may be used to predict the electrode height from the neural tissue and, thereby, predict the preferred location. Alternatively, electrode height may be measured directly to predict the preferred location.

Abstract: The invention provides methods for measuring stroke volume from a patient using a transbrachial electro-velocimetry waveform measured using an impedance sensor together with a motion waveform measured using a motion sensor.

Abstract: In order to reliably cut off a living tissue by using a microwave in a surgical operation without causing excessive damage to the living tissue or without bleeding, it is necessary to suppress energy attenuation until the microwave reaches electrode blades for nipping, coagulating, and cutting off a tissue. However, it is difficult to suppress the energy attenuation. The present invention relates to a medical treatment device capable of reliably cutting off a living tissue by using a microwave while sealing vasculature by coagulating the living tissue without excessively damaging the living tissue. Specifically, the present invention relates to a medical treatment device including a movable first electrode blade connected to an external conductor and a fixed second electrode blade connected directly to a central electrode.

Abstract: Subject matter such as a method or apparatus can include an implantable antenna assembly, comprising a dielectric shell including first and second substantially parallel outer face portions, and a third outer face portion extending between the first and second portions, a spiral conductor extending along the first, second, and third portions on a surface of the dielectric shell. The dielectric shell and spiral conductor can be configured to be mechanically attached to a dielectric compartment, such as configured to be coupled to a housing of an implantable medical device. In an example, the implantable antenna assembly is configured to be electrically coupled to an implantable telemetry circuit configured to wirelessly transfer information electromagnetically using the implantable telemetry antenna, such as included as a portion of an implantable medical device.

Abstract: The present invention is an improved package and configuration for an implantable retinal prosthesis. The retinal prosthesis of the present invention includes an electrode array suitable to be mounted in close proximity to a retina, an electronics package and inductive receiving coil mounted next to each other on a strap surrounding the sclera so that the height above the sclera of the prosthesis is minimized.

Abstract: Systems and methods are disclosed to determine one or more sensing zones on a body surface for electrocardiographic mapping of a region of interest associated with the heart. The sensing zone can be utilized to facilitate acquisition, processing and mapping of electrical activity for the corresponding region of interest. In other examples, an application-specific arrangement of electrodes can also be provided based on the sensing zone that is determined for the region of interest.